Anzeige
Mehr »
Freitag, 06.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QEF3 | ISIN: CA98980M1095 | Ticker-Symbol:
NASDAQ
04.03.25 | 22:00
0,095 US-Dollar
0,00 % 0,000
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
ZOMEDICA CORP Chart 1 Jahr
5-Tage-Chart
ZOMEDICA CORP 5-Tage-Chart

Aktuelle News zur ZOMEDICA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
21.05.Zomedica Corp.: Zomedica Launches Enhanced Equine Insulin Assay for the TRUFORMA Diagnostic Platform Featuring an Extended Range and Automatic Sample Dilution256The TRUFORMA Platform now has the widest dynamic range (without manual dilution) available either at the Point of Care or from a Reference Lab ANN ARBOR, MI / ACCESS Newswire / May 21, 2025 / Zomedica...
► Artikel lesen
20.05.Zomedica Corp.: Zomedica Unveils Exclusive Fourth Friday at Four Webinar Series to Explore Cutting-Edge Veterinary Innovations428Engaging Sessions to Highlight Game-Changing Technologies, Expert Insights, and Growth Opportunities in Animal Health Featuring Zomedica Products ANN ARBOR, MI / ACCESS Newswire / May 19, 2025 / Zomedica...
► Artikel lesen
15.05.Zomedica reports Q1 results3
ZOMEDICA Aktie jetzt für 0€ handeln
15.05.Zomedica Corp.: Zomedica Announces First Quarter 2025 Financial Results: Revenue of $6.5 Million; 68% Gross Margin, and $65 Million in Liquidity to Support Growth331ANN ARBOR, MI / ACCESS Newswire / May 15, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for...
► Artikel lesen
15.05.Zomedica Corp. - 8-K, Current Report5
13.05.Zomedica Corp.: Zomedica Launches Groundbreaking Equine Asthma Clinical Registry Featuring PulseVet Shock Wave Therapy245Innovative Registry Harnesses Shock Wave Therapy to Advance Non-Drug Equine Asthma Treatment and Drive Evidence-Based Veterinary Care ANN ARBOR, MI / ACCESS Newswire / May 13, 2025 / Zomedica Corp....
► Artikel lesen
09.05.Zomedica Corp.: Zomedica to Report First Quarter 2025 Financial Results with a Business Update on Thursday, May 15, 2025 at 4:30 pm ET257ANN ARBOR, MI / ACCESS Newswire / May 9, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for...
► Artikel lesen
30.04.Zomedica Corp. - 8-K, Current Report1
01.04.Zomedica Corp. (ZOMDF): Among Stocks Insiders Were Buying In Q1 20251
13.03.Zomedica Corp.: Zomedica Reports Record Revenue of $7.9 Million for the Fourth Quarter and $27.3 Million for the Full Year 2024; 70% Gross Margin, and $71 Million in Liquidity to Support Growth344ANN ARBOR, MI / ACCESS Newswire / March 13, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products...
► Artikel lesen
13.03.Zomedica Corp. - 10-K, Annual Report4
13.03.NSE - Zomedica Corp. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities3
05.03.Zomedica Corp. - 8-K, Current Report1
04.03.Zomedica Corp. Announces Transition to OTCQB Venture Market438Zomedica's ticker symbol will change to ZOMDF ANN ARBOR, MI / ACCESS Newswire / March 4, 2025 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a leading veterinary health company...
► Artikel lesen
04.03.NYSE American to Commence Delisting Proceedings Against Zomedica Corp. (ZOM)120NEW YORK--(BUSINESS WIRE)--NYSE American LLC ("NYSE American" or the "Exchange") announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the common shares...
► Artikel lesen
26.02.Zomedica Corp.: Zomedica to Report Fourth Quarter and Full Year 2024 Financial Results with a Business Update on March 13th at 4:30 p.m. ET291ANN ARBOR, MI / ACCESS Newswire / February 26, 2025 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic...
► Artikel lesen
12.02.Zomedica Corp.: Zomedica Improves Efficiency and Cuts Costs by Moving to New Headquarters322Relocation to More Efficient Space Supports Growth While Reducing Overhead by Over $200,000 Annually ANN ARBOR, MI / ACCESS Newswire / February 12, 2025 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica"...
► Artikel lesen
06.02.Zomedica Corp.: Zomedica Launches the TRUFORMA Enhanced Endogenous ACTH Assay to aid in Equine PPID Diagnosis374Zomedica continues to redefine what is possible in point of care diagnostics with the TRUFORMA biosensor platform ANN ARBOR, MI / ACCESS Newswire / February 6, 2025 / Zomedica Corp. (NYSE American:ZOM)...
► Artikel lesen
07.01.Zomedica Corp.: Zomedica Announces License & Supply Agreement with Cresilon Inc. to Market and Sell Vetigel Hemostatic Gel in the Animal Health Market652License Agreement Expands Zomedica's Portfolio with Revolutionary Hemostatic Technology ANN ARBOR, MI / ACCESSWIRE / January 7, 2025 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company")...
► Artikel lesen
23.12.24Zomedica Unveils New Canine Tests Offering Faster Diagnostics for Heart and Breeding Health10
Weiter >>
47 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1